Halberd Co. (OTCMKTS:HALB) Sees Significant Drop in Short Interest

Halberd Co. (OTCMKTS:HALB) was the target of a significant drop in short interest during the month of August. As of August 15th, there was short interest totalling 14,300 shares, a drop of 7.7% from the July 31st total of 15,500 shares. Based on an average trading volume of 1,013,900 shares, the short-interest ratio is presently 0.0 days.

Halberd Price Performance

Halberd stock opened at $0.01 on Monday. Halberd has a 12-month low of $0.00 and a 12-month high of $0.01. The firm’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.